First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 21(2021), 6 vom: 06. Juni, Seite e147 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fiorentini, Simona [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ACE2 protein, human |
|---|
| Anmerkungen: |
Date Completed 01.07.2021 Date Revised 01.07.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(21)00007-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320133680 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320133680 | ||
| 003 | DE-627 | ||
| 005 | 20231225172930.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(21)00007-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1067.xml |
| 035 | |a (DE-627)NLM320133680 | ||
| 035 | |a (NLM)33450180 | ||
| 035 | |a (PII)S1473-3099(21)00007-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fiorentini, Simona |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.07.2021 | ||
| 500 | |a Date Revised 01.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a ACE2 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 700 | 1 | |a Messali, Serena |e verfasserin |4 aut | |
| 700 | 1 | |a Zani, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Caccuri, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Giovanetti, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Ciccozzi, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Caruso, Arnaldo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 21(2021), 6 vom: 06. Juni, Seite e147 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:6 |g day:06 |g month:06 |g pages:e147 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(21)00007-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2021 |e 6 |b 06 |c 06 |h e147 | ||